SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001789769-24-000082
Filing Date
2024-08-13
Accepted
2024-08-13 17:00:15
Documents
15
Period of Report
2024-08-13
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K til-20240813.htm   iXBRL 8-K 32764
2 EX-99.1 q2-24er.htm EX-99.1 84083
6 GRAPHIC imagea.jpg GRAPHIC 3565
  Complete submission text file 0001789769-24-000082.txt   261764

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT til-20240813.xsd EX-101.SCH 1892
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT til-20240813_lab.xml EX-101.LAB 23449
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT til-20240813_pre.xml EX-101.PRE 13576
17 EXTRACTED XBRL INSTANCE DOCUMENT til-20240813_htm.xml XML 3091
Mailing Address 3963 MAPLE AVENUE SUITE 350 DALLAS TX 75219
Business Address 3963 MAPLE AVENUE SUITE 350 DALLAS TX 75219 (972) 499-3350
Instil Bio, Inc. (Filer) CIK: 0001789769 (see all company filings)

IRS No.: 832072195 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40215 | Film No.: 241202678
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)